Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-462-0 | CAS number: 95-88-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Additional toxicological data
Administrative data
- Endpoint:
- additional toxicological information
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Study period:
- 17.02.-19.03.2004
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
- Type of study / information:
- Type: in vitro penetration through pig skin
- Principles of method if other than guideline:
- Draft OECD guidelines on in vitro percutaneous penetration (OECD 2003) / European Commission guidance document (2002) and ECETOC recommendations (1993)
- GLP compliance:
- yes
Test material
- Reference substance name:
- 4-chlororesorcinol
- EC Number:
- 202-462-0
- EC Name:
- 4-chlororesorcinol
- Cas Number:
- 95-88-5
- Molecular formula:
- C6H5ClO2
- IUPAC Name:
- 4-chlorobenzene-1,3-diol
- Test material form:
- other:
- Remarks:
- beige powder
- Details on test material:
- Molecular weight: 144.65
Constituent 1
- Specific details on test material used for the study:
- Unlabelled test material:
4-chlororesorcinol
Radiolabelled test material:
4-chlororesorcinol, [Ring-14C(U)]
Radiochemical purity: 99.78%
Specific activity: 56.20mCi/mmol; 0.389mCi/mg
Molecular weight: 144.58
Results and discussion
Applicant's summary and conclusion
- Conclusions:
- 1. The vast majority of the applied A 012 in the cream formulations was removed after a contact period of 0.5h by gently washing the skin with a mild detergent solution (99.5% from the formulation with hydrogen peroxide and 104% from the formulation without hydrogen peroxide). Less A 012 was washed offthe skin at 0.5h from the aqueous solution (62.9%) using the same procedure.
2. Less than 1 % of the A 012 applied remained in the stratum corneum at the end of the study from the cream application and approximately 6 - 10 times more was found in the stratum corneum following the aqueous application.
3. After washing and tape stripping, only 1.05% and 1.30% A 012 was found in the remaining epidermis/dermis from the applications with or without hydrogen peroxide, respectively and 6.63% from the aqueous application.
4. Only 0.448% and 0.651 % A 012 penetrated through the skin into the receptor fluid from the cream applications with or without hydrogen peroxide, respectively and 14.2% from the aqueous application at the end of the 48h sampling period.
5. The systemically available dose for the cream formulations with and without hydrogen peroxide and aqueous solution would be approximately 1.50%, 1.95% and 20.8%, respectively. Therefore, these calculated amounts could be used for risk assessments.
6. The results obtained in this study demonstrate that the penetration of A 012, from these formulations, through dermatomed pig skin is very slow when compared with the penetration rates of other penetrants measured using this in vitro technique with human skin (Dugard et al, 1984; Dugard and Scott, 1984).
7. These data demonstrate that the systemic availability, after dermal exposure to A 012 from two realistic formulations, would be low especially under normal use conditions in combination with a hydrogen peroxide developer and would be significantly less than that available from a solution of A 012 in water. - Executive summary:
1.1 Study design
The penetration of A 012 has been measured in vitro through dermatomed pig skin from a standard cream formulation (with and without hydrogen peroxide) and from a solution in water. The aqueous solution and formulated material, all containing a nominal 2.5% w/w A 012, were applied to the dermatomed membranes at a nominal rate of 10mg/cm2 and left unoccluded. The applications were rinsed off after a 0.5 h contact period, with the penetration of A 012 though the membrane being assessed throughout the entire 48h exposure period. At the end of the exposure period, the distribution of A 012 in the test system was assessed, which included a tape stripping technique to determine its distribution in the skin.
The applications and exposure conditions were designed to simulate potential human dermal exposure to the formulation during normal use and compare the penetration of A 012 from a standard formulation (with and without hydrogen peroxide) with the penetration from an aqueous solution.
Samples collected during this study were analysed by liquid scintillation counting (LSC).
1.2 Results
1.2.1 A 012 cream formulation with hydrogen peroxide
The dermal penetration of A 012 from the cream formulation with hydrogen peroxide through dermatomed pig skin was low and the vast majority ofthe <lose was recovered in the wash at 0.5h. Most of the penetration occurred during the first 4 hours giving a penetration rate of 0.110 µg/cm2/h, after which a small amount of A 012 penetrated, making the penetration rate over the 4 -48h sampling period 0.016µg/cm2/h and the overall rate (0 - 48h) 0.023µg/cm2/h. After the 0.5h exposure period, the amount which had penetrated was 0.062µg/cm2 (=0.024%) and after 48h, the amount penetrated was l. l7µg/cm2 (=0.448%). A small proportion of the dose was found adsorbed to the stratum corneum and absorbed in the remaining epidermis/dermis. The overall quantity found to be bioavailable (absorbed and penetrated) within 48 hours under the given study conditions was calculated to be 1.50% (= 3.91 µg/cm2) of the topically applied amount. The total recovery ofradioactivity from this application was 103%.
1.2.2 A 012 cream formulation without hydrogen peroxide
The dermal penetration of A 012 from the cream formulation without hydrogen peroxide was low and very similar to the application with hydrogen peroxide and again most of the dose was recovered in the washes. Most of the penetration occurred during the first 4 hours giving a penetration rate of 0.108µg/cm2/h, after which a small amount of A 012 penetrated, making the penetration rate over the 4 -48h sampling period 0.030µg/cm2/h and the overall rate
(0- 48h) 0.037µg/cm2/h. At 0.5h, the amount which had penetrated the membrane was 0.022µg/cm2 (=0.008%) and at 48h the amount penetrated was 1.69µg/cm2 (=0.651 %). A small proportion of the dose was found adsorbed to the stratum corneum and absorbed in the remaining epidermis/dermis. The overall quantity found to be bioavailable (absorbed and penetrated) within 48 hours under the given study conditions was calculated to be 1.95% (= 5.05µg/cm2) of the topically applied amount. The total recovery ofradioactivity from this application was 107%.
1.2.3 A 012 aqueous solution
The dermal penetration of A 012 from the aqueous solution was low but greater than from the cream formulations so a smaller proportion of the dose was recovered in the washes. Penetration occurred during the whole 48 hour test period giving a rate of 2.03µg/cm2/h during the first 4 hours (for comparison with the cream formulations) and the penetration rate between the 4 and 48h time period was 0.623µg/cm2/h. The overall rate (0-48h) was 0. 770µg/cm2/h. At 0.5h the amount which had penetrated the membrane was 0.111µg/cm2 (=0.044%) and at 48h the amount penetrated was 35.8µg/cm2 (=14.2%). A small proportion of the dose was found adsorbed to the stratum corneum and absorbed in the remaining epidermis/dermis. The overall quantity found to be bioavailable (absorbed and penetrated) within 48 hours under the given study conditions was calculated to be 20.8% (= 52.6µg/cm2) of the topically applied amount. The total recovery of radioactivity from this application was 105%.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.